1783 related articles for article (PubMed ID: 25001183)
1. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
3. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
Yan S; Wang H; Chen X; Liang C; Shang W; Wang L; Li J; Xu D
Cancer Lett; 2020 Sep; 488():18-26. PubMed ID: 32473243
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
5. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
8. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
10. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A.
Wei L; Sun C; Zhang Y; Han N; Sun S
Gene Ther; 2022 Feb; 29(1-2):28-40. PubMed ID: 32533103
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P
Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296
[TBL] [Abstract][Full Text] [Related]
12. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
13. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
15. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.
Yongchun Z; Linwei T; Xicai W; Lianhua Y; Guangqiang Z; Ming Y; Guanjian L; Yujie L; Yunchao H
Cancer Lett; 2014 May; 347(1):65-74. PubMed ID: 24486218
[TBL] [Abstract][Full Text] [Related]
18. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Han J; Hu J; Sun F; Bian H; Tang B; Fang X
Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.
Zhou JY; Chen X; Zhao J; Bao Z; Chen X; Zhang P; Liu ZF; Zhou JY
Cancer Lett; 2014 Sep; 351(2):265-71. PubMed ID: 24983493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
